Home › Companies › VAXCYTE INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and VAXCYTE INC.’s Form 8-K, filed June 10, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 6, 2024: 5 items on VAXCYTE INC.’s Form 8-K, filed June 10, 2024: 2 approved · 3 passed (calculated).
Notable dissent: 1 director (16.3% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025 2025-2026
Activist investors: Ra Capital Management, L.P. (13F, 7.2%, as of September 30, 2026) · Caligan Partners (13F, 1.4%, as of September 30, 2026)
Explore VAXCYTE INC. in the interactive database Compare manager voting policies
These tallies are VAXCYTE INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 10, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Annie Drapeau | 82,886,170 | -- | -- | 16,143,582 | 4,817,013 | 84% | Passed (calculated) | — |
| Elect Director: Teri Loxam | 96,840,846 | -- | -- | 2,188,906 | 4,817,013 | 98% | Passed (calculated) | — |
| Elect Director: Carlos Paya, M.D., Ph.D. | 96,685,408 | -- | -- | 2,344,344 | 4,817,013 | 98% | Passed (calculated) | — |
| 2. The ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. The appointment | 103,807,993 | 14,745 | 24,027 | -- | -- | 99.9% | Approved | — |
| 3. The approval, on a non-binding, advisory basis of the compensation of the Company's named executive officers. The approval of the non-binding resolution on named executive officer compensation | 91,072,269 | 7,934,248 | 23,235 | -- | 4,817,013 | 92% | Approved | — |
Source: VAXCYTE INC., Form 8-K, filed with the SEC on June 10, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
305 asset managers disclosed a vote on at least one VAXCYTE INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 8 wordings of this item as funds reported it.
84% Majority: yes · of votes cast
Description as filed by funds: Election of Class I Directors Nominees would serve until the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Annie Drapeau
VAXCYTE INC.’s own tally for this item (“Elect Director: Annie Drapeau”): 82,886,170 for, 16,143,582 withheld, per its Form 8-K filed June 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 84% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 109 asset managers below reported 50,146,931 for, 72 against, 7,174,902 withheld, 1,400,247 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 12,891,803 | 0 | 0 | 20,579 | For |
| Vanguard | 12,083,278 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 3,891,173 | 0 | 0 | 933,284 | Mixed |
| T. Rowe Price | 4,492,337 | 0 | 0 | 0 | For |
| BlackRock | 4,344,959 | 0 | 0 | 0 | For |
| Capital Group | 3,719,065 | 0 | 0 | 0 | For |
| State Street | 1,066,769 | 0 | 0 | 39,120 | For |
| FRANKLIN STRATEGIC SERIES | 911,602 | 0 | 0 | 0 | For |
| JPMorgan | 876,111 | 0 | 0 | 0 | For |
| Charles Schwab | 835,423 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 657,206 | 0 | 0 | 0 | For |
| Prudential/PGIM | 644,862 | 0 | 0 | 3,697 | For |
| AllianceBernstein | 0 | 0 | 0 | 633,068 | Withhold |
| Invesco | 0 | 0 | 0 | 614,853 | Withhold |
| Equitable | 291,588 | 0 | 0 | 234,119 | Mixed |
| Bridge Builder Trust | 19,764 | 0 | 483,120 | 0 | Abstain |
| Federated Hermes | 425,750 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 0 | 0 | 411,801 | 0 | Abstain |
| American Century | 0 | 0 | 0 | 404,240 | Withhold |
| Jackson National | 117,592 | 0 | 286,361 | 0 | Mixed |
| NEW ECONOMY FUND | 396,483 | 0 | 0 | 0 | For |
| Hartford | 386,424 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 0 | 0 | 0 | 360,895 | Withhold |
| AB DISCOVERY GROWTH FUND, INC. | 0 | 0 | 0 | 314,955 | Withhold |
| Lord Abbett | 0 | 0 | 0 | 305,355 | Withhold |
Showing the 25 largest of 109 asset managers. All 109 are in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Class I Directors Nominees would serve until the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Carlos Paya, M.D., Ph.D.
VAXCYTE INC.’s own tally for this item (“Elect Director: Carlos Paya, M.D., Ph.D.”): 96,685,408 for, 2,344,344 withheld, per its Form 8-K filed June 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 109 asset managers below reported 57,332,912 for, 1,370,628 withheld, 18,612 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 12,891,803 | 0 | 0 | 20,579 | For |
| Vanguard | 12,083,278 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,824,457 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,492,337 | 0 | 0 | 0 | For |
| BlackRock | 4,344,959 | 0 | 0 | 0 | For |
| Capital Group | 3,719,065 | 0 | 0 | 0 | For |
| State Street | 1,104,715 | 0 | 0 | 1,174 | For |
| FRANKLIN STRATEGIC SERIES | 911,602 | 0 | 0 | 0 | For |
| JPMorgan | 876,111 | 0 | 0 | 0 | For |
| Charles Schwab | 835,423 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 657,206 | 0 | 0 | 0 | For |
| Prudential/PGIM | 648,559 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 0 | 0 | 633,068 | Withhold |
| Invesco | 614,853 | 0 | 0 | 0 | For |
| Equitable | 291,588 | 0 | 0 | 234,119 | Mixed |
| Bridge Builder Trust | 502,884 | 0 | 0 | 0 | For |
| Federated Hermes | 425,750 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 411,801 | 0 | 0 | 0 | For |
| American Century | 404,240 | 0 | 0 | 0 | For |
| Jackson National | 403,953 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 396,483 | 0 | 0 | 0 | For |
| Hartford | 386,424 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 360,895 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 0 | 0 | 0 | 314,955 | Withhold |
| Lord Abbett | 305,355 | 0 | 0 | 0 | For |
Showing the 25 largest of 109 asset managers. All 109 are in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Class I Directors Nominees would serve until the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Teri Loxam
VAXCYTE INC.’s own tally for this item (“Elect Director: Teri Loxam”): 96,840,846 for, 2,188,906 withheld, per its Form 8-K filed June 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 109 asset managers below reported 57,343,457 for, 1,360,083 withheld, 18,612 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 12,891,803 | 0 | 0 | 20,579 | For |
| Vanguard | 12,083,278 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,824,457 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,492,337 | 0 | 0 | 0 | For |
| BlackRock | 4,344,959 | 0 | 0 | 0 | For |
| Capital Group | 3,719,065 | 0 | 0 | 0 | For |
| State Street | 1,104,715 | 0 | 0 | 1,174 | For |
| FRANKLIN STRATEGIC SERIES | 911,602 | 0 | 0 | 0 | For |
| JPMorgan | 876,111 | 0 | 0 | 0 | For |
| Charles Schwab | 835,423 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 657,206 | 0 | 0 | 0 | For |
| Prudential/PGIM | 648,559 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 0 | 0 | 633,068 | Withhold |
| Invesco | 614,853 | 0 | 0 | 0 | For |
| Equitable | 291,588 | 0 | 0 | 234,119 | Mixed |
| Bridge Builder Trust | 502,884 | 0 | 0 | 0 | For |
| Federated Hermes | 425,750 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 411,801 | 0 | 0 | 0 | For |
| American Century | 404,240 | 0 | 0 | 0 | For |
| Jackson National | 403,953 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 396,483 | 0 | 0 | 0 | For |
| Hartford | 386,424 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 360,895 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 0 | 0 | 0 | 314,955 | Withhold |
| Lord Abbett | 305,355 | 0 | 0 | 0 | For |
Showing the 25 largest of 109 asset managers. All 109 are in the interactive database (link above).
Combines 11 wordings of this item as funds reported it.
92% Approved · of votes cast
Prior year: 89.8% for (June 13, 2023 meeting) ▲ 2.2 pts
Description as filed by funds: Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.
VAXCYTE INC.’s own tally for this item (“3. The approval, on a non-binding, advisory basis of the compensation of the Company's named executive officers. The approval of the non-binding resolution on named executive officer compensation”): 91,072,269 for, 7,934,248 against — passed, per its Form 8-K filed June 10, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The approval of the non-binding resolution on named executive officer compensation was approved by the votes indicated:”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 12,912,382 | 0 | 0 | 0 | For |
| Vanguard | 12,083,278 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,824,457 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,492,337 | 0 | 0 | 0 | For |
| BlackRock | 4,344,959 | 0 | 0 | 0 | For |
| Capital Group | 0 | 3,719,065 | 0 | 0 | Against |
| State Street | 1,103,385 | 2,504 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 911,602 | 0 | 0 | 0 | For |
| JPMorgan | 876,111 | 0 | 0 | 0 | For |
| Charles Schwab | 835,423 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 657,206 | 0 | 0 | 0 | For |
| Prudential/PGIM | 648,559 | 0 | 0 | 0 | For |
| AllianceBernstein | 633,068 | 0 | 0 | 0 | For |
| Invesco | 0 | 614,853 | 0 | 0 | Against |
| Equitable | 525,707 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 502,884 | 0 | 0 | 0 | For |
| Federated Hermes | 425,750 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 411,801 | 0 | 0 | 0 | For |
| American Century | 0 | 404,240 | 0 | 0 | Against |
| Jackson National | 248,085 | 155,868 | 0 | 0 | Mixed |
| NEW ECONOMY FUND | 0 | 396,483 | 0 | 0 | Against |
| Hartford | 386,424 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 0 | 360,895 | 0 | 0 | Against |
| AB DISCOVERY GROWTH FUND, INC. | 314,955 | 0 | 0 | 0 | For |
| Lord Abbett | 305,355 | 0 | 0 | 0 | For |
Fund voting reports, all 108 managers: 52,132,614 for, 6,536,141 against, 20,481 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 15,266,690 | 0 | 0 | 0 | For |
| Janus Henderson | 7,490,808 | 0 | 0 | 0 | For |
| T. Rowe Price | 6,528,318 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 6,212,874 | 0 | 0 | 0 | For |
| Wellington | 4,552,913 | 0 | 0 | 0 | For |
| Capital Research Global Investors | 0 | 4,140,113 | 0 | 0 | Against |
| State Street | 3,034,259 | 2,636 | 0 | 0 | For |
| BlackRock | 2,981,047 | 10,058 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 1,883,810 | 0 | 0 | 0 | For |
| AllianceBernstein | 1,637,418 | 0 | 0 | 0 | For |
| FRED ALGER MANAGEMENT, LLC | 60,662 | 1,239,173 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 1,245,205 | 0 | 0 | 0 | For |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,158,912 | 0 | 0 | 0 | For |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1,040,521 | 50,001 | 0 | 0 | For |
| JENNISON ASSOCIATES LLC | 1,071,252 | 2,276 | 0 | 0 | For |
| JPMorgan | 1,045,818 | 0 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 1,034,692 | 0 | 0 | 0 | For |
| COMMODORE CAPITAL LP | 860,000 | 0 | 0 | 0 | For |
| Charles Schwab | 854,408 | 0 | 0 | 0 | For |
| BRAIDWELL LP | 849,186 | 0 | 0 | 0 | For |
| Novo Holdings A/S | 845,000 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 769,728 | 0 | 0 | 0 | For |
| Invesco | 0 | 765,595 | 0 | 0 | Against |
| PERCEPTIVE ADVISORS LLC | 715,159 | 0 | 0 | 0 | For |
| Kynam Capital Management, LP | 0 | 0 | 0 | 642,913 | Withhold |
Institutional-manager reports, all 226 managers: 71,031,908 for, 7,303,240 against, 642,913 withheld, 224 not voted, 106,024 1 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Prior year: 100.0% for (June 13, 2023 meeting) unchanged
Description as filed by funds: Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.
VAXCYTE INC.’s own tally for this item (“2. The ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. The appointment”): 103,807,993 for, 14,745 against — passed, per its Form 8-K filed June 10, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The appointment was ratified by the votes indicated:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 110 asset managers below reported 58,696,186 for, 6,241 against, 20,481 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 12,912,382 | 0 | 0 | 0 | For |
| Vanguard | 12,083,278 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,824,457 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,492,337 | 0 | 0 | 0 | For |
| BlackRock | 4,344,959 | 0 | 0 | 0 | For |
| Capital Group | 3,719,065 | 0 | 0 | 0 | For |
| State Street | 1,105,889 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 911,602 | 0 | 0 | 0 | For |
| JPMorgan | 876,111 | 0 | 0 | 0 | For |
| Charles Schwab | 835,423 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 657,206 | 0 | 0 | 0 | For |
| Prudential/PGIM | 648,559 | 0 | 0 | 0 | For |
| AllianceBernstein | 633,068 | 0 | 0 | 0 | For |
| Invesco | 614,853 | 0 | 0 | 0 | For |
| Equitable | 525,707 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 502,884 | 0 | 0 | 0 | For |
| Federated Hermes | 425,750 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 411,801 | 0 | 0 | 0 | For |
| American Century | 404,240 | 0 | 0 | 0 | For |
| Jackson National | 403,953 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 396,483 | 0 | 0 | 0 | For |
| Hartford | 386,424 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 360,895 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 314,955 | 0 | 0 | 0 | For |
| Lord Abbett | 305,355 | 0 | 0 | 0 | For |
Showing the 25 largest of 110 asset managers. All 110 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 108,755,731 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 11.87% |
| 2 | Vanguard | 11.11% |
| 3 | JANUS INVESTMENT FUND | 4.44% |
| 4 | T. Rowe Price | 4.13% |
| 5 | BlackRock | 4.00% |
| 6 | Capital Group | 3.42% |
| 7 | State Street | 1.02% |
| 8 | FRANKLIN STRATEGIC SERIES | 0.84% |
| 9 | JPMorgan | 0.81% |
| 10 | Charles Schwab | 0.77% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 14.04% |
| 2 | Janus Henderson | 6.89% |
| 3 | T. Rowe Price | 6.00% |
| 4 | RA CAPITAL MANAGEMENT, L.P. | 5.71% |
| 5 | Wellington | 4.19% |
| 6 | Capital Research Global Investors | 3.81% |
| 7 | State Street | 2.79% |
| 8 | BlackRock | 2.75% |
| 9 | FRANKLIN ADVISERS INC | 1.73% |
| 10 | AllianceBernstein | 1.51% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| FMR LLC | 14,213,365 | 13.07% | Proxy statement (DEF 14A), proxy filed April 15, 2024 |
| FMR (Fidelity) | 12,509,933 | 11.50% | Form 13F, quarter ended March 31, 2024 |
| Vanguard Group | 12,320,453 | 11.33% | Form 13F, quarter ended March 31, 2024 |
| BlackRock | 9,955,978 | 9.15% | Form 13F, quarter ended March 31, 2024 |
| RA Capital Management, L.P. | 9,685,079 | 8.91% | Proxy statement (DEF 14A), proxy filed April 15, 2024 |
| Janus Henderson Group plc | 6,981,376 | 6.42% | Proxy statement (DEF 14A), proxy filed April 15, 2024 |
| State Street | 3,337,092 | 3.07% | Form 13F, quarter ended March 31, 2024 |
| T. Rowe Price | 3,176,181 | 2.92% | Form 13F, quarter ended March 31, 2024 |
| Geode Capital | 2,287,375 | 2.10% | Form 13F, quarter ended March 31, 2024 |
| Franklin Templeton | 2,147,656 | 1.97% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 108,755,731 shares outstanding, as reported by VAXCYTE INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At VAXCYTE INC.'s shareholder meeting held June 6, 2024, in the 2023-2024 proxy season, 305 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 2,475 separate fund positions. On the most widely held item on that ballot — Approval, on a non-binding, advisory basis, of the compensation of the Company's named… — VAXCYTE INC.'s filing reports the proposal as approved, with 92% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: VAXCYTE INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 10, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from VAXCYTE INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
VAXCYTE INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “VAXCYTE (PCVX) 2024 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/vaxcyte-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.